Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial
2019 · The Lancet Neurology · 624 citations
https://doi.org/10.1016/s1474-4422(19)30395-3
H
Haicun Shi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
2.1K
Citations
14
h-index
19
i10-index
Haicun Shi is an academic researcher from Yancheng Third People's Hospital. The author has contributed to research in topics: Parkinson's Disease Mechanisms and Treatments & Acute Ischemic Stroke Management & Functional Brain Connectivity Studies. The author has an h-index of 14, co-authored 44 publications.
ORCID: 0000-0001-5640-1434Papers by this author
worksEndovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial
2019 · The Lancet Neurology · 624 citations
https://doi.org/10.1016/s1474-4422(19)30395-3
Cerebrospinal fluid and blood levels of neurofilament light chain in Parkinson disease
2020 · Medicine · 3 citations
https://doi.org/10.1097/md.0000000000021458
Correlation between the MNCD classification-based staging of Parkinson’s disease and quality of life: a cross-sectional study
2024 · Journal of Neural Transmission · 3 citations
https://doi.org/10.1007/s00702-024-02756-4
Prognostic Prediction Model for Endovascular Treatment of Acute Anterior Circulation Ischemic Stroke Based on Rapid Processing of PerfusIon and Diffusion Software
2024 · World Neurosurgery · 0 citations
https://doi.org/10.1016/j.wneu.2024.11.075
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat